{
    "summary": "The Fair Price Device Act amends the Federal Food, Drug, and Cosmetic Act to address generic drugs used with medical devices. It modifies requirements for generic drug approval, requiring more information demonstrating that the generic drug used with a device will have the same clinical effect and safety profile as the brand-name drug with its device. The bill specifies the types of information needed, including comparative device performance data and human factors studies. The bill also updates language regarding changes allowed in generic drug applications.",
    "tags": [
        "Healthcare",
        "Consumer protection",
        "Technology regulation",
        "Opioid crisis",
        "Healthcare access"
    ],
    "category": "Healthcare & Public Health"
}